Navigation Links
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Date:2/2/2009

CORONA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the U.S. Federal Trade Commission (FTC) and the State of California have filed a lawsuit in the United States District Court for the Central District of California alleging that the Company's 2006 patent lawsuit settlement with Solvay Pharmaceuticals Inc. related to AndroGel(R) 1% (testosterone gel) CIII is unlawful.

"We are disappointed that the FTC has decided to challenge our patent settlement, as we believe the agreement fully complies with both the spirit and letter of the antitrust and consumer protection laws, as interpreted by numerous appellate courts throughout the U.S.," said Paul Bisaro, Watson's President and Chief Executive Officer. "Importantly, our settlement promotes competition and confers a meaningful benefit to U.S. consumers by providing for, among other things, the entry of a generic version of AndroGel(R) five years prior to the expiration of the AndroGel(R) patents. We intend to vigorously defend ourselves in this matter."

In 2003, Watson submitted an Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of AndroGel. Solvay initiated litigation against Watson alleging that its product infringed Solvay's patent. Under terms of a 2006 settlement agreement, Solvay granted Watson a non-exclusive license to the U.S. patents covering AndroGel. Watson agreed not to commence marketing its generic equivalent product until August 31, 2015 or the date on which another generic product enters the U.S. market, whichever occurs first. Additionally, Watson agreed to forfeit its 180-day marketing exclusivity on the product awarded under the Hatch-Waxman Act.

<
'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... San Diego, CA (PRWEB) May 20, 2013 ... country and around the world will make the pilgrimage ... for the 2nd annual Digital Health Summer Summit ... two-day conference provides a unique forum to showcase the ... lessons and best practices, and network with some of ...
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... 20 (HealthDay News) -- Although many hospital intensive ... staff to help improve outcomes, new research suggests ... Since one-third of teaching hospitals in the ... staff a nighttime physician in the ICU, the ... doctors away from hospitals with fewer resources, the ...
(Date:5/20/2013)... 20, 2013 In celebration of National ... scientific accomplishments achieved at The Feinstein Institute for ... scientists, Advancing Women in Science and Medicine (AWSM) ... 17. Scientists, educators, business and community leaders from ... achievements of women in science. , “Women face ...
(Date:5/20/2013)... about toothpaste that transforms the sweet flavor of orange ... that mysterious sensory phenomenon in colorful, animated detail ... Society,s award-winning Bytesize Science video series at ... largest scientific society, explains that the mainstay ingredients in ... SLS for short. When you brush your teeth, SLS ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... HOUSTON Regardless of an individual,s dietary and lifestyle ... deprived neighborhood may increase a person,s risk for death, ... Cancer Research Conference on Frontiers in Cancer Prevention Research, ... Diet and Health Study and found that people living ...
... M.D., Professor of Medicine at Case Western Reserve University ... Medical Center has been awarded a 10 year, $19.7M ... Prevention (CDC) as an international clinical trials site for ... is a partnership of U.S. and international clinical investigators ...
... , NEW YORK, Dec. ... report is available in its catalogue: , ... http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html , Mesenchymal stem cells (MSCs) are ... of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic ...
... , , Through her ... of urological patient care , BALTIMORE, Dec. 8 ... its Executive Director Sandra Vassos was presented with the Star ... Star Breakfast in New York City. The Star Award recognizes ...
... ... to hip replacement surgery in patients 20 – 60 years of age. , ... (PRWEB) December 8, 2009 -- Dr. Einhorn’s ... offers patients a less invasive alternative to hip replacement., , ,Using non-embryonic stem cells harvested ...
... , CHARLOTTE, N.C., Dec. ... the Blue Cross and Blue Shield Association (BCBSA) as ... EPLS and USA PATRIOT Act compliance solutions. Under the contract, ... its member Blue Cross and Blue Shield companies nationwide. ...
Cached Medicine News:Health News:People living in poorer neighborhoods at increased risk for death, worse health risks 2Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 3Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 4Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... Sequent Medical, Inc. announced today that it ... family of WEB ® Aneurysm Embolization Devices, and ... in select neurovascular centers in Europe.  The SL family ... enable physicians to treat a broader range of aneurysms ... are made possible by further advancement of Sequent Medical,s ...
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Cardiology publishes positive ATLAS clinical dataNATICK, Mass., Feb. ... BSX ) today announced that it has submitted ... the final modules of the Company,s Pre-Market Approval ... Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte ...
... 4 Here are highlights from the February issue ... cite this publication as often as you wish. ... is required. Reprinting is allowed for a fee. ... permit: Visit www.bookstore.mayoclinic.com or call toll-free for ...
Cached Medicine Technology:Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 2February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 3February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 4February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 5
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
... Arthroscopy Scissor is ideal for excising soft tissue ... in the joint. The serrated edge on the ... as hold tissue within the jaws for more ... right jaw curvatures, are the perfect tools for ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
Medicine Products: